DaxibotulinumtoxinA for Injection has a prolonged duration of response in the treatment of glabellar lines: pooled data from two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 and SAKURA 2)
Published: 18 November 2019| Version 1 | DOI: 10.17632/z8mxtfpzp2.1
Contributors:
Vince Bertucci, Nowell Solish, Joely Kaufman-Janette, Steve Yoelin, Ava Shamban, Joel Schlessinger, Daniel Snyder, Conor Gallagher, Yan Liu, Gill Shears, Roman RubioDescription
Supplemental figures: 1. Disposition of participants 2. Participants with at least a 1-point improvement in glabellar line severity 3. Participants with improvement on global aesthetic improvement scale 4. Duration of improvement in glabellar line severity before return to baseline levels 5. Participant global satisfaction at week 4 Supplemental tables: 1. Efficacy and satisfaction rating scales 2. Key eligibility criteria for study participation 3. Baseline demographics 4. Summary of glabellar line response duration data
Files
Categories
Dermatology, Botulinum Toxin, Cosmetic Facial Surgery